Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2019-11-05 13:02:28
Oslo, 5 November 2019: Ultimovacs ASA ("Ultimovacs", ticker ULTIMO), a pharmaceutical company developing novel immunotherapies against cancer, invites to a presentation of its third quarter 2019 results on Thursday 14 November 2019. The presentation by the company's management team will take place at Oslo Cancer Cluster Innovation Park (Ullernchausséen 64) in Jónas Einarsson Auditorium (2nd floor, entrance 2B) at 09:00 CET on Thursday 14 November 2019. The presentation can be followed as a live webcast (access through link https://webtv.hegnar.no/presentation.php?webcastId=98164491) which will also be available on our website. It will be possible to post questions during the presentation through the webcast. The report and presentation will also be available on the company website from 08:00 CET the same day. For further information, please see www.ultimovacs.com or contact: Øyvind Kongstun Arnesen, CEO oeyvind.arnesen@ultimovacs.com, +47 469 33 810 Hans Vassgård Eid, CFO hans.eid@ultimovacs.com, +47 469 19 822